352 related articles for article (PubMed ID: 32303635)
41. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation.
Galloway SE; Reed ML; Russell CJ; Steinhauer DA
PLoS Pathog; 2013 Feb; 9(2):e1003151. PubMed ID: 23459660
[TBL] [Abstract][Full Text] [Related]
42. Novel insights into proteolytic cleavage of influenza virus hemagglutinin.
Bertram S; Glowacka I; Steffen I; Kühl A; Pöhlmann S
Rev Med Virol; 2010 Sep; 20(5):298-310. PubMed ID: 20629046
[TBL] [Abstract][Full Text] [Related]
43. Unique Transcriptional Architecture in Airway Epithelial Cells and Macrophages Shapes Distinct Responses following Influenza Virus Infection
Ma JZ; Ng WC; Zappia L; Gearing LJ; Olshansky M; Pham K; Cheong K; Hsu A; Turner SJ; Wijburg O; Londrigan SL; Brooks AG; Reading PC
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626665
[TBL] [Abstract][Full Text] [Related]
44. Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium.
Böttcher-Friebertshäuser E; Klenk HD; Garten W
Pathog Dis; 2013 Nov; 69(2):87-100. PubMed ID: 23821437
[TBL] [Abstract][Full Text] [Related]
45. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells.
Rodriguez-Frandsen A; Martin-Sancho L; Gounder AP; Chang MW; Liu WC; De Jesus PD; von Recum-Knepper J; Dutra MS; Huffmaster NJ; Chavarria M; Mena I; Riva L; Nguyen CB; Dobariya S; Herbert KM; Benner C; Albrecht RA; García-Sastre A; Chanda SK
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776276
[TBL] [Abstract][Full Text] [Related]
46. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.
Kido H; Okumura Y; Yamada H; Le TQ; Yano M
Curr Pharm Des; 2007; 13(4):405-14. PubMed ID: 17311557
[TBL] [Abstract][Full Text] [Related]
47. Detection of nonhemagglutinating influenza a(h3) viruses by enzyme-linked immunosorbent assay in quantitative influenza virus culture.
van Baalen CA; Els C; Sprong L; van Beek R; van der Vries E; Osterhaus AD; Rimmelzwaan GF
J Clin Microbiol; 2014 May; 52(5):1672-7. PubMed ID: 24622097
[TBL] [Abstract][Full Text] [Related]
48. TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1.
Zmora P; Hoffmann M; Kollmus H; Moldenhauer AS; Danov O; Braun A; Winkler M; Schughart K; Pöhlmann S
J Biol Chem; 2018 Sep; 293(36):13863-13873. PubMed ID: 29976755
[TBL] [Abstract][Full Text] [Related]
49. Activation of c-jun N-terminal kinase upon influenza A virus (IAV) infection is independent of pathogen-related receptors but dependent on amino acid sequence variations of IAV NS1.
Nacken W; Anhlan D; Hrincius ER; Mostafa A; Wolff T; Sadewasser A; Pleschka S; Ehrhardt C; Ludwig S
J Virol; 2014 Aug; 88(16):8843-52. PubMed ID: 24872593
[TBL] [Abstract][Full Text] [Related]
50. Novel Reassortant Human-Like H3N2 and H3N1 Influenza A Viruses Detected in Pigs Are Virulent and Antigenically Distinct from Swine Viruses Endemic to the United States.
Rajão DS; Gauger PC; Anderson TK; Lewis NS; Abente EJ; Killian ML; Perez DR; Sutton TC; Zhang J; Vincent AL
J Virol; 2015 Nov; 89(22):11213-22. PubMed ID: 26311895
[TBL] [Abstract][Full Text] [Related]
51. Zoonotic Risk, Pathogenesis, and Transmission of Avian-Origin H3N2 Canine Influenza Virus.
Sun H; Blackmon S; Yang G; Waters K; Li T; Tangwangvivat R; Xu Y; Shyu D; Wen F; Cooley J; Senter L; Lin X; Jarman R; Hanson L; Webby R; Wan XF
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814512
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection.
Bahgat MM; Błazejewska P; Schughart K
Virol J; 2011 Jan; 8():27. PubMed ID: 21251300
[TBL] [Abstract][Full Text] [Related]
53. Finding proteases that make cells go viral.
Aguilar HC; Buchholz DW
J Biol Chem; 2020 Aug; 295(33):11408-11409. PubMed ID: 32817125
[TBL] [Abstract][Full Text] [Related]
54. Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system.
Patel U; Gingerich A; Widman L; Sarr D; Tripp RA; Rada B
PLoS One; 2018; 13(7):e0199167. PubMed ID: 30044776
[TBL] [Abstract][Full Text] [Related]
55. Germacrone inhibits early stages of influenza virus infection.
Liao Q; Qian Z; Liu R; An L; Chen X
Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
[TBL] [Abstract][Full Text] [Related]
56. Cleavage activation of human-adapted influenza virus subtypes by kallikrein-related peptidases 5 and 12.
Hamilton BS; Whittaker GR
J Biol Chem; 2013 Jun; 288(24):17399-407. PubMed ID: 23612974
[TBL] [Abstract][Full Text] [Related]
57. miR-29a is a negative regulator of influenza virus infection through targeting of the frizzled 5 receptor.
Yang X; Liang Y; Bamunuarachchi G; Xu Y; Vaddadi K; Pushparaj S; Xu D; Zhu Z; Blaha R; Huang C; Liu L
Arch Virol; 2021 Feb; 166(2):363-373. PubMed ID: 33206218
[TBL] [Abstract][Full Text] [Related]
58. A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site.
Straus MR; Whittaker GR
PLoS One; 2017; 12(3):e0174827. PubMed ID: 28358853
[TBL] [Abstract][Full Text] [Related]
59. Exposure to ozone modulates human airway protease/antiprotease balance contributing to increased influenza A infection.
Kesic MJ; Meyer M; Bauer R; Jaspers I
PLoS One; 2012; 7(4):e35108. PubMed ID: 22496898
[TBL] [Abstract][Full Text] [Related]
60. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
